Journal of Hematology & Thromboembolic Diseases
Open Access

Department of Research and Development, University of Groningen, Groningen, Netherlands

Publications

• Opinion Article   
  Crizanlizumab: A Novel Monoclonal Antibody for Sickle Cell Disease Management
  Author(s): Fenton Neill*
  
  DOI: 10.35248/2329-8790.24.12.614

  HTML PDF